Physician profile
Jeffrey Long
NPI 1629177936
$7,511.72
in general payments reported to CMS, 2019-2025
8 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what 89% of Therapeutic Radiology providers received nationally (typical 2025 total: $179).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,500 · 2024: $4,388 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,998 · Grant: $300 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,997.50 |
| Grant | $300.00 |
| Food and Beverage | $214.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| F. Hoffmann-La Roche Ag | $7,087.60 | 2023-2025 | |
| Zap Surgical Systems, INC. | $300.00 | 2025 | Zap-X Treatment Planning Software, Zap-X Treatment Delivery Software, Zap-X Mv Imager |
| Geron Corporation | $30.67 | 2025 | Rytelo |
| Novocure INC. | $23.96 | 2025 | Optune Gio |
| Siemens Medical Solutions USA, INC. | $22.12 | 2024 | Somatom Go.Top |
| Janssen Biotech, INC. | $18.77 | 2024 | Rybrevant |
| Novartis Pharmaceuticals Corporation | $14.31 | 2024 | |
| Genzyme Corporation | $14.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.